Dr. Nguyen Anh Dung, MD, Specialist Level I in Oncology
Dr. Nguyen Anh Dung is a radiation oncologist with over 8 years of experience in cancer care. After graduating from the University of Medicine and Pharmacy at Ho Chi Minh City in 2017, he completed his Specialist Level I in Oncology in 2022.
He has participated in multiple international training programs in chemotherapy and radiotherapy in Luxembourg and Taiwan, gaining expertise in advanced treatment techniques such as intensity-modulated radiotherapy (IMRT), stereotactic radiosurgery for brain, liver, and lung tumors, and deep inspiration breath-hold (DIBH) for breast cancer to minimize cardiac exposure.
With dedication, empathy, and professionalism, Dr. Dung strives to deliver optimal treatment outcomes and accompany patients throughout their journey against cancer.
- Comprehensive consultation, diagnosis, and management of cancer patients.
- Multimodal treatment planning: Developing integrated treatment protocols, with a focus on head and neck, gastrointestinal, thoracic, prostate, breast, and gynecologic cancers.
- Radiation oncology: Applying the latest advances and modern techniques to optimize treatment outcomes and minimize side effects.
- Prevention and treatment of adverse effects and complications from radiotherapy, chemotherapy, targeted therapy, immunotherapy...
2011 - 2017: University of Medicine and Pharmacy Ho Chi Minh City: Medical Doctor
June, 2019: Centre Hospitalier Emile Mayrisch, Luxembourg: Safety procedures in chemotherapy handling
Nov, 2019 to Jan, 2020: Kaoshiung Veterans General Hospital, Kaoshiung City, Taiwan: General Radiation Therapy
2020 - 2022: First degree Specialist in Oncology, University of Medicine and Pharmacy Ho Chi Minh City
Jan, 2018 – Feb, 2026: Thu Duc General Hospital – Oncology Department – Oncologist
March 2026 – September 2026: FV Hospital – Radiation Oncologist
Sep, 2026 - Now: Vinmec Central Park International Hospital
Vietnam Cancer Society
American Society of Clinical Oncology (ASCO)
European Society for Medical Oncology (ESMO)